Clinical trials: Warfarin Sodium Causing Adverse Effects in Therapeutic Use
Anticoagulant-induced Bleeding, Warfarin Sodium Causing Adverse Effects in Therapeutic Use
AI-based Social Software to Manage wARfarin Therapy
The investigators have demonstrated that social software could improve warfarin therapy quality by Human management. however,the efficiency of management will decline if patients' number expands huge.
- Trial name
- AI-SMART (NCT03870581)
- Testing
- AI-based social software management model, Human-based social software management model
- Where
- 2 sites in China
- Volunteers
- 500 people
- Sponsor
- Wuhan Asia Heart Hospital
Anticoagulants Causing Adverse Effects in Therapeutic Use, Patient Compliance
Social-software iMproving wARfarin Therapy
Poor anticoagulation quality is a major problem among Chinese patients receiving warfarin therapy in traditional health care settings. Improving warfarin therapy has been crucial for Chinese patients.
- Trial name
- SMART (NCT03264937)
- Testing
- Social-software management
- Where
- China
- Volunteers
- 735 people
- Sponsor
- Wuhan Asia Heart Hospital
Warfarin Sodium Causing Adverse Effects in Therapeutic Use
A Prospective Cohort Study on Warfarin Personalized Medication
Analyze the impact of the degree of blood vessel aging on the anticoagulant effect and bleeding risk of warfarin. Evaluating the possibility of using the degree of blood vessel aging to guide individualized use of the…
- Trial name
- NCT06428110
- Where
- China
- Volunteers
- 272 people
- Sponsor
- Haobin Li